SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-217982
Filing Date
2022-08-11
Accepted
2022-08-11 07:36:03
Documents
14
Period of Report
2022-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d367465d8k.htm   iXBRL 8-K 26215
2 EX-99.1 d367465dex991.htm EX-99.1 109027
6 GRAPHIC g367465g0811075501078.jpg GRAPHIC 6125
  Complete submission text file 0001193125-22-217982.txt   282738

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wve-20220811.xsd EX-101.SCH 2881
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20220811_lab.xml EX-101.LAB 17927
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20220811_pre.xml EX-101.PRE 11255
8 EXTRACTED XBRL INSTANCE DOCUMENT d367465d8k_htm.xml XML 3380
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 221153716
SIC: 2834 Pharmaceutical Preparations